On June 30, 2022, at the headquarters of Vietnam Gene & Cell Technology Joint Stock Company (VGCT), a meeting took place between VGCT and N-Biotek, a leading Korean company with extensive experience in the research, production, and application of stem cells.
With a vision to become Asia’s leading gene and cell technology manufacturer and a developer of new biotherapeutic products, we continuously seek and connect with top global companies specializing in innovative technologies for treatment and healthcare.
N-Biotek is a leading Korean company in the field of stem cells, providing comprehensive solutions for stem cell production and processing at both research and industrial scales. The company also owns high-efficiency adipose-derived stem cell isolation technology and develops biocosmetic products based on stem cells.
During the meeting held on June 30, 2022, at VGCT’s headquarters, both parties engaged in in-depth discussions about development directions and potential stages of collaboration. This partnership promises to bring stem cell technology closer to patients, offering advanced healthcare and beauty services based on the latest stem cell innovations.
